Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not sure about the news alone. Possibly, but I think increased utilization, revenues and profitability will be the big drivers of share price increase after some bigger generic approvals.
Revenues will increase dramatically after news of new packaging, warehouse facility is up and running and adding to gross sales
Hi Longs, (I have muted all the goatlanders) let's start early discussing the next quarter numbers - this is not yet the posting of your estimates - but more the potential catalysts that will impact the numbers that you will post two weeks before the teleconference
I say -
1. Prasco may surprise us.
2. Adderall drought in pharmacies may play in our favor
3. Kirko Kirkov may have cooked something nice for us
4. feel free to add ...
Cheers
They know why they are here ..... To distract and cause a disturbance as best they can !!!!!!!!!!
They know who sent them here as well, as do you & I know,
We have one hope,
SEC
IB_🤴🏻
What if the " someone" in your conspiracy novel
Is the " Rat" keeping the price down for the Mikah
acquisition of ELTP for a few pennies per share.
How grand would that be for the zealots that kiss
his picture every morning....omg that would be hilarious!!....it is possible, LOFL
and the short position you rant about incessantly,
.21 to .12 is over 60% they have fled already with
their proceeds.....now what ??
I still say ignore option is your best option.
Thanks, enjoy the day
She/Him is the Board 🤡 !!!!!!!!!!!!
Quote: "@NASDAQ2020
I am a legitimate owner of this company stock. I come her looking for tidbits of information regarding the company business activities.
You joined IH 08/29/2012.
You show 25,793 total posts under ELTP
You average 6.08 posts EVERY DAY for the last 11.6 YEARS
I don't know what your plan in or why you are really here with constant boasting about buying more on a weekly basis but the funds didn't arrive or somethign else happened. We have no way to either confirm or deny what you say. The constant bombardment of boasting that appears to be unachievable by any ordinary penny stock follower makes me wonder.
I am a believer in ELTP but I keep my anticipation to myself. I have no business boasting about the future that may or may not happen. A little cheerleading is always nice but you have a serious problem unless you are being paid for your efforts. I cannot say that any of your posts have resulted in any benefit to any of the readers in a positive manner.
Hubris
That probably goes for the other members bragging about the trips to various exotic or expensive places when they know they won't be doing that regardless of what happens.
I am tempted to ignore, not sure yet." End Quote
IB_🤴🏻
HyperSeeker96, what is your opinion on Elite going forward ??????????????
Don't just be a Troll,
IB_🤴🏻
Hi JimmyJoe, I’m going to put a bet on Tarifa to win the Oaks. That’s a low confidence bet. I have a lot more confidence (and money at stake) with Elite. 🍀
Those are exactly the two reasons.
I sold some in the $0.19's that I had bought in the $0.04's & $0.05's but I didn't sell any that I bought when Jerry was CEO ......
IB_🤴🏻
He never bought any.
So you sold your shares?
See, I think whoever is requiring you to be here has a vested interest in the company. Since you don't know why you have to be here, that makes the story more interesting. Years of your life on this job which is sad in and of itself.
Now the company has extremely strong financials, minimal debt, profitable with an absurdly low PE. It is a prime candidate to be bought out. Biggest products are all ahead and the revenues and earnings are already substantial compared to market cap.
So the only reasons you would be here are because there is a large short position that needs to be covered or someone is trying to prep for acquiring the company and needs the stock price cheap.
What's your best guess as to why you are required to be here?
Will a Monster show its head ?
Secret MIKAH Program
signed back on December 3, 2018:
NOTE 20. RELATED PARTY AGREEMENTS WITH MIKAH PHARMA LLC
-- On December 3, 2018, the Company executed a development agreement with Mikah, pursuant to which Mikah and the Company will collaborate to develop and commercialize generic products including formulation development, analytical method development, bioequivalence studies and manufacture of development batches of generic products.
-- The Company received a total of $480,000 from Mikah as an advance payment for the purchase of pharmaceutical materials relating to future product development conducted pursuant to this agreement. This amount was recorded as a deposit and contained within the customer deposits financial statement line item on the consolidated balance sheet.
-- As of the date of this report, the Company has purchased raw materials with an aggregate cost of $542,214 pursuant to this agreement. As of March 31, 2020, the balance due from Mikah was $62,214 and was included in the financial statement line of prepaid expenses and other current assets on the accompanying consolidated balance sheet.
Lockin and Loadin for the next CC
HammerTime Near !
It’s about to Get Real. !!!!!
X 1. Cash Flow Positive Status - 5 years
X 2. Purchase building housing their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million Approved and Launched
X 4. Adderall XR $1.56 Billion Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. In house marketing and distribution: Kirko Kirkov, Doug Plassche and their teams
X 7. Prasco/Burel Adderall agreement starting January 1st 2024
X 8. First shipment Adderall XR to PRASCO Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic Vyvanse - $5.1 BILLION - FDA submission Dec 2023
X 11. FDA Acceptance of Generic OxyContin Sept 2023
__12. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
X 13. Vigabatrin Approval $233 Million
_
X 14. Pyros Settle Vigabatrin -VigPoder trade mark challenge then Launch
__15. Generic Methotrexate Approval- Antimetabolite $42 Million
__16. $50 million in yearly revenues
X 17. Lease additional manufacturing space and storage vault for new Needle Mover ANDAs - Jan 2024
X 18. PE ratio below 8
__19. Generate revenues over $20 million/quarter
__20. Generic OxyContin Approval - FIRST TO FILE Aug 17, 2023 $720 Million
__21. Prevail over Purdue in Generic OxyContin infringement suit - 6 month stay
__22. Legislation to make manufacturing generic drugs more profitable
__23. European distribution - Dexcel partnership approval by Israeli Health
__24. Full ownership of Adderall IR $ 335 Million
__25. Full ownership of Adderall XR $ 1.56 Billion
__26. Generic Concerta- $1.2 BILLION FDA submission
__27. $100 million in yearly revenue
__28. Generic Vyvanse Approval and Launch
__29. $200 million in yearly revenue
__30. Deep pocket partner for SequestOx
__31. Patented Unique ADF (w/o naltrexone)-- NDA
__32. Mikah ANDA (s)
__33. Undisclosed ANDAs/NDAs
__34. DollarLand PPS
__35. Uplist to the NASDAQ Exchange
__36. ELTP Elite Pharmaceutical Buyout - less than 2 1/2 years from Feb 2024
__37. Vegas Baby !!!!!!!
Maybe the ignore option might be a good choice for you. I apologize if my questions cause you strife. If you are not concerned about ELTPi why reply ??
And the political MB thing , not sure where that
comes from, at all.
Last post today, have a stress free evening.
As always I'm here for you.
I would rather talk about the fantasy that you have been calling for for over 10 years now ....
You know, "Dollar Land" ........ You thought it would come in 2014, it didn't ....you thought it would come in 2015, it didn't .... you were sure it would come in 2016 with SequestOx "The Game Changer", it didn't ..... Every year you thought it would come, it hasn't .....
Do you ever get tired of dreaming about a fantasy ???????????????
IB_🤴🏻
Tell us about your goats
Three of ya working hard today. Does trolling political message boards pay better or the same? Worried you might be replaced by bots? That keeps your pay down I am guessing?
Elite has a 🤡 at the company & a 🤡 here on the board ..............
Care to guess who each one might be ???????????
LoL LoL
IB_🤴🏻
I trusted the CEO when I first seen that Mikah would be winding down operations !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Fool me once, shame on you, fool me twice, shame on me ................
SEC
IB_🤴🏻
But.....now concerned about PPS, "for possible
early retirement", why ??
You proclaimed buy out WAS the "golden ticket" what happened ??
Are you reconsidering ?? What have you found ??
Can you share this Intel ??
I'm here for you, let me know
Oh I must have mis understood I thought dollar land was a year That was 9 years ago lol But the CEO said so So it must be true
For the 5th time Mikah is winding down and ceasing to exist lmao!!! Trust me I’m the CEO
I’m not sure if there is anyone home there?
Let me know what you like James. My dilemma is Forever Young and Encino.
Forever Young is a real unknown. Encino hasn't been tested with horses of this caliber but his speed numbers are impressive.
Also he has not been tested at this distance. Forever Young has with horses overseas.
Let me know who you like in both if you have time. TIA
$Elite is my horse in generic pharma. Always has been. 🤣🐴😂
$ELTP baby~!
Can you believe that you are required to post here everyday for years? Guess you can't be embarrassed. Lol
Yep, we are celebrating finally reaching "Dollar Land" .................
I know, I know .... It's a fantasy but we can pretend !!!!!!!!!!!!!!!!!!!!!!!!!!
The Board 🤡 is hosting the party ..... yeah yeah, we are also pretending to be in Vegas,
IB_🤴🏻
Do you think Mikah would offer more than $0.20 per share at the buyout ?????????????????
That is a premium at today's prices,
IB_🤴🏻
Interested in PPS (unlike you), because I may be able to accelerate my retirement date.
Are all you guys in Vegas and did not tell me to come over? LOL
Wake up
Interesting read, thanks.
But....I was told by the lottery club captains the buy out is coming, you know the buy out that the
myopics have guaranteed in "22 months".
Why now would you be concerned with PPS ??
Enjoy the day, I'm here for you
the answer to Pharma Sleuth famous question: Do you know why you are here?
Financial Times article from March 26th 2024
Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.com T&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found at https://www.ft.com/tour.
https://www.ft.com/content/4fe0f032-07e5-41d7-ac85-cceb252129a3
File under: huge if true. A group of Wall Street traders maliciously drove down the share price of a Maryland biotech with a promising new brain cancer vaccine, in pursuit of the marginal profits to be made by buying the stock cheaply and selling it back to the market.
That, at least, was the allegation made by Northwest Biotherapeutics in a suit filed against seven broker-dealers including Virtu and Ken Griffin’s Citadel Securities in late 2022.
It accused the firms of “repeated spoofing” by using their trading platforms to place tens of millions of orders to sell NWBO that they had no intention of fulfilling. These orders were visible to the rest of the market, the complaint alleged, which led other investors to dump the shares, hammering NWBO’s valuation even as a key clinical trial yielded impressive results.
Predictably, the claims sent conspiracy-minded Redditors — including some of those who previously pumped meme stocks such as Gamestop — into a frenzy. Their refrain for several months has been that hedge funds “want to bury this company”, while largely avoiding mention of factors that might have dissuaded investors from buying into NWBO, such as a study questioning the design of its cancer trial and a negative news report on its results. Northwest had also been mired in governance problems, settling with the SEC over failures in financial reporting oversight.
Last month, NWBO and its Reddit fans were rebuffed by a Manhattan court, which granted Citadel et al’s motion to dismiss the case.
But there was a sting in the tail. In his report recommending dismissal, magistrate Gary Stein concluded that while the company had not yet done enough to tie the trading in question to losses sustained by selling shares at the artificially low prices on specific dates, almost all of NWBO’s other claims were prima facie plausible enough to be allowed to proceed.
An attempted distinction by Citadel Securities and others between orders that were cancelled or merely reduced in volume was “unconvincing”, Stein wrote. He also concluded that at this stage in the litigation, it mattered not whether they were executing orders on behalf of clients, as they exerted “control over the high-speed trading algorithms” behind the trades.
He further found that when “viewed in the light most favourable” to the plaintiff, the “allegations amply support the inference that defendants’ conduct affected the market price for NWBO stock”. In a line that seemed destined to make its way on to the r/wallstreetbets message boards on Reddit, Stein further called the claims “cogent and at least as compelling as the inference that defendants were simply engaged in legitimate trading activity.”
The report came hot on the heels of another spoofing decision in the same New York courthouse, in a civil case brought by Bermudian hedge fund Harrington against Bank of America Merrill Lynch, CIBC and TD Securities. That suit — which was referenced by Stein — survived a motion to dismiss and is currently scheduled to go to trial as early as this year.
NWBO intends to refile its complaint within days. This time around, if a judge finds the deficiencies in the biotech’s case have been fixed, it could pave the way for the so-called discovery process in which Citadel Securities and its co-defendants would be compelled to hand over internal records and relevant communications. Critics of high-frequency trading firms, who claim they have an outsized and malign influence on global markets, will be watching closely.
Citadel Securities labelled the case a “malicious lawsuit [that] blatantly misrepresents how the market functions in an attempt to shake down the world’s leading liquidity providers”, and neither Northwest nor Harrington is necessarily any closer to proving their claims. To date, no spoofing case outside those brought by the US prosecutors or regulators has prevailed.
But the default stance adopted by market-makers — who claim allegations of market manipulation are implausible while declining to divulge the commercially sensitive intricacies of their high-tech platforms — has now been effectively knocked back.
Recommended
News in-depthUnhedged podcast
Inside the traders’ black box
Stein wrote that the fact NWBO did not specify what algorithmic trading programmes were used by defendants to execute their schemes or how they were used was not an impediment to its case. “It is hard to imagine how any spoofing case would survive the motion to dismiss stage if?.?.?.?‘facts solely within the defendant’s knowledge,’ were required to be set forth in the complaint”, he added. In other words, if Citadel Securities and its ilk are to beat this case and prevent a string of copycat suits, they will probably have to give the rest of us more of a peek behind the curtain.
joe.miller@ft.com
@ELTP Emperor - your goatland connection seems to f up.
10 yr olds stones aren’t big enough to make the move I did. One liner? You want to see the rest of portfolio? Lolol bro you heeeeellllllllllaaa mad about my position. I knocked this one out of the park. And I have you and the clown crew to thank for it! You were so obvious it made me a little hesitant at first. I thought I was getting double dutched, but then I considered the IQ level I was going against and it was an easy home run. In two years it’s a grand slam.
No Derby post #17 has ever won. There’s always a first. #17 to WIN.
GO ELTP.
‘Nuff said!
BUY $ELTP$
Thanks for the picks. I’m still doing my handicapping. I agree Fierceness is a worthy favorite, providing he gets out of the gate without issues. I haven’t looked at the Oaks yet. I’m just a casual player, it’s fun…. But I definitely support the racing industry rather than the other way around lol.
Anytime Hyder~! Your anointed REAL King knows the hard cold truth about $ELTP~!
If I was fishing this would be my KEEPER~!
To all of my loyal subjects, I hope to remain your King with the next revenue pick coming.
If I lose I will be playing the Beatles "I'm a Loser" 10 consecutive times over. I love that song anyway,
$ELTP STRONG~!
JamesF1, yes I have my Kentucky Derby pick. How about you~?
Do you also have anything for the Kentucky Oaks (Friday), the ladies~? I also have that one too.
Derby I like Fierceness, especially on the outside post. Sierra Leone, deep closer, Catching Freedom another closer and finally
Honor Marie yet another closer. The speed in this race is going to be interesting and may mess up my picks.
I do like Sierra Leone no matter what post. This won't be my only 4. I also like Forever Young to be a surprise. Horse is just too talented. Another I may play is Power Squeeze. Maybe I'll play a pick 5~? I dunno........
Kentucky Oaks, I like Thorpedo Anna. Ways and Means, Just FYI and Tarifa.
All the above in the order of like.
How about you~? Gonna be a fun 2 days.
$ELTP baby~!
Caveat, Derby
Rabid anti-Elite-ism for decades. It’s actually really weird when you think about it. Lol. You’d think this company murdered entire families. I’ve invested in companies that didn’t pan out. I didn’t hang around like herpes for years and years, I simply moved on…
Get a dog, play a sport, something. Sheesh.
Again, why were you assigned here and what is your goal.
Still waiting for the 5 verbatim lies........... nothing..........eh~?
Shareholders know. Trying to keep the horse in the barn. One day the fly will be left open and the Elite horse will be out of the barn.
Your loss.
$ELTP baby~!
Looks like Elite hired somebody new.
https://www.indeed.com/cmp/Elite-Pharmaceuticals,-Inc.-1/jobs
They used to post 5, now down to 4.
Getting ready for the new plant.
You have to be at least a little curious about why you have been assigned to this board. Best guess?
Highly profitable rapidly growing company with very low debt. What's the reason?
lol better loosen your tin foil hat bro It’s cutting off circulation to your brain
Hi Jimmy Joe, You mention horses. Do you have a Kentucky Derby pick? GLTA
Any 10 year old could have posted what you posted about you ownership It was a one line of nothing
lol all you just did is make excuses for the LiES They still are Lies And if you think I used defamatory statements sue my ass Your like a little child who got caught up in lies but instead of admitting the truth you make excuses for them SUE Me Jerk
Followers
|
966
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
403289
|
Created
|
03/24/09
|
Type
|
Free
|
Moderators jimr1717 mrwrn2010 NASDAQ2020 IB_ namtae Dr JoeBarducci |
Senior Moderator: IB_
Posted: 7/02/2024
________________________________________________________________________________________________________________
Elite Pharmaceuticals, Inc. |
Website | Location | Employees | Facility | CEO |
www.elitepharma.com | Northvale, New Jersey | 64 | 85,000 sq ft | Nasrat Hakim |
Products & Pipeline | ||||
Drug | Market Size | Status | Competitors | Marketed By |
Adderall IR | 389.8 M | On Market | 15 | Elite |
Adderall XR | 1.56 B | On Market | 10 | Elite & Prasco |
Dantrolene | 6.3 M | On Market | 2 | Elite |
Isradipine | 5.5 M | On Market | 1 | Elite |
Loxapine | 5 M | On Market | 2 | Elite |
Phendimetrazine | 4.5 M | On Market | 4 | Elite |
Trimipramine | 2 M | On Market | 1 | Elite |
Naltrexone | 16 M | On Market | 5 | Precision Dose |
Phentermine Capsules | 7.5 M | On Market | 6 | Precision Dose |
Phentermine Tablets | 40 M | On Market | 8 | Precision Dose |
Vigabatrin | 233.7 M | On Market | 13 | Pyros |
Doxycycline | 85 M | Approved (Discontinued) | 9 | ---------- |
Tylenol with Codeine | 45 M | Approved | 5 | ---------- |
Dopamine Agonist | 12 M | Filed with FDA - 22 Dec 2022 | ---------- | ---------- |
Methotrexate | 64.3M | Approved - 16 May 2024 | 8 | Elite |
Percocet | 500 M | Approved | --------- | ---------- |
Norco | 477 M | Approved | --------- | ---------- |
Methadone | 30 M | Approved | --------- | ---------- |
OxyContin | 720 M | Filed with FDA - 17 Aug 2023 | ---------- | ---------- |
Vyvanse | 5.1 B | Filed with FDA - 21 Dec 2023 | 14 | ---------- |
Concerta | 1.16 B | In Development (Final Stages) | 9 | ---------- |
Financials | ||||
Fiscal Year | Revenue | Change | Net Income | Change |
2019 | 7,568,508 | ---------- | (9,279,321) | ---------- |
2020 | 17,994,639 | +137.76% | (2,240,351) | +75.86% |
2021 | 25,380,749 | +41.05% | 5,088,421 | +327.13% |
2022 | 32,262,117 | +27.11% | 8,898,245 | +74.87% |
2023 | 34,155,114 | +5.87% | 3,561,846 | -59.97% |
2024 | 56,625,128 | +65.79% | 20,108,631 | +464.56% |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |